1-877-526-8540
Immigration Law Associates, PC

Articles Tagged: VOICE Study

CAPRISA Trial and 1% Tenofovir Gel in Reducing the Risk of Contracting HIV

by

Tenofovir gel could prevent new HIV infections in close to a half million women over the next decade in South Africa alone. The results from this trial are a significant first step toward establishing the effectiveness of antiretroviral drugs for HIV prevention; confirmatory studies are now urgently needed.